These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 32286218

  • 1. [Severe dabigatran intoxication complicated by insufficient reversal by idarucizumab].
    Hellfritzsch M, Hvas AM.
    Ugeskr Laeger; 2020 Apr 06; 182(15):. PubMed ID: 32286218
    [Abstract] [Full Text] [Related]

  • 2. Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review.
    Ohya Y, Makihara N, Wakisaka K, Morita T, Ago T, Kitazono T, Takaba H.
    J Stroke Cerebrovasc Dis; 2018 Jul 06; 27(7):e128-e131. PubMed ID: 29555397
    [Abstract] [Full Text] [Related]

  • 3. [The first use of iv. idarucizumab for dabigatran reversal in Hungary].
    Driesz L, Barabás É, Bodócs I, Szántó Z, Herr G, Bencsik G, Pál L, Borbola J.
    Orv Hetil; 2017 Mar 06; 158(10):387-392. PubMed ID: 28270004
    [Abstract] [Full Text] [Related]

  • 4. Management of Dabigatran-Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis.
    Marino KK, Santiago RA, Dew RB, Berliner N, Connors JM, Connell NT, Tucker JK.
    Pharmacotherapy; 2016 Oct 06; 36(10):e160-e165. PubMed ID: 27581709
    [Abstract] [Full Text] [Related]

  • 5. The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran.
    Simon A, Domanovits H, Ay C, Sengoelge G, Levy JH, Spiel AO.
    J Thromb Haemost; 2017 Jul 06; 15(7):1317-1321. PubMed ID: 28426914
    [Abstract] [Full Text] [Related]

  • 6. Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.
    Sié P.
    Drug Des Devel Ther; 2016 Jul 06; 10():1683-9. PubMed ID: 27274201
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Life-threatening bleeding due to persistent dabigatran effect in a patient with sepsis despite idarucizumab therapy and haemodialysis.
    Humphries K, Huggan P, Stiles M, Martynoga R.
    BMJ Case Rep; 2019 Aug 21; 12(8):. PubMed ID: 31439551
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Persistent life-threatening hemorrhage after administration of idarucizumab.
    Alhashem HM, Avendano C, Hayes BD, Winters ME.
    Am J Emerg Med; 2017 Jan 21; 35(1):193.e3-193.e5. PubMed ID: 27439386
    [No Abstract] [Full Text] [Related]

  • 12. idarucizumab (PRAXBIND°). Don't rely too heavily on this dabigatran antidote.
    Prescrire Int; 2016 Nov 21; 25(176):260-263. PubMed ID: 30715821
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.
    Agosti S, Casalino L, Rocci E, Zaccone G, Rota E.
    J Med Case Rep; 2017 Aug 15; 11(1):224. PubMed ID: 28806993
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The first experience with dabigatran antidote in the University Hospital Pilsen].
    Šlechtová J, Hajšmanová Z, Lavičková A, Šigutová P.
    Cas Lek Cesk; 2016 Aug 15; 155(8):442-444. PubMed ID: 28098476
    [Abstract] [Full Text] [Related]

  • 20. Evidence Supporting Idarucizumab for the Reversal of Dabigatran.
    Pollack CV.
    Am J Med; 2016 Nov 15; 129(11S):S73-S79. PubMed ID: 27568285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.